CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450705648
- Phone
- 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,865,893
- in 5 filings, $1.9M under 10b5-1 plans
Net −$1,865,893. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-28 | Chan Mitchell Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | Chan Mitchell Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | Goldman Jonathan Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | Goldman Jonathan Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | Truex Samantha Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | Truex Samantha Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | KANTOFF AARON Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | KANTOFF AARON Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | KAPLAN GILLA Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | KAPLAN GILLA Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | Almenoff June Sherie Director | Option exercise | +3,167 | 3,167 | ||
| 2025-03-28 | Almenoff June Sherie Director | Option exercise · Restricted Stock Units | −3,167 | 6,333 | ||
| 2025-03-28 | Sullivan Christopher Ryan Chief Financial Officer | Option exercise | +24,200 | 24,206 | ||
| 2025-03-28 | Sullivan Christopher Ryan Chief Financial Officer | Shares withheld for taxes | −7,285 | $8.46 | $62K | 16,921 |
| 2025-03-28 | Sullivan Christopher Ryan Chief Financial Officer | Option exercise · Restricted Stock Units | −24,200 | 48,400 | ||
| 2025-03-28 | NEIL GARRY ARTHUR Chief Executive Officer | Option exercise | +64,867 | 64,927 | ||
| 2025-03-28 | NEIL GARRY ARTHUR Chief Executive Officer | Shares withheld for taxes | −17,787 | $8.46 | $150K | 47,140 |
| 2025-03-28 | NEIL GARRY ARTHUR Chief Executive Officer | Option exercise · Restricted Stock Units | +64,867 | 129,733 | ||
| 2025-03-25 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-01-28 | VARKI PAUL Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 9 of 11 · 202 trades